Myths vs facts: APOE and Blutzucker

APOE is primarily known for its role in lipid metabolism and Alzheimer's disease. Its link to blood sugar is weaker and more controversial. Carriers of the ε4 allele may have slightly increased insulin resistance and a modestly higher risk of type 2 diabetes in some studies, but effect sizes are small and not consistently replicated. The ε2 allele has been associated with lower glucose levels. Direct-to-consumer tests like MyBody-X can detect these variants, but the clinical utility for blood sugar management is limited. Lifestyle factors (diet, exercise, weight) dominate glucose control. An APOE test alone cannot diagnose or guide diabetes prevention. Caution: a risk allele does not guarantee disease. Evidence is based on human studies (GWAS, meta-analyses) with moderate but mixed results.